Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simultaneous Laparoscopic Repair of Iatrogenic Lumbar and Inguinal Hernias Using Combined TAPP and IPOM: A Case Report.

The Tokai journal of experimental and clinical medicine·2026
Same author

Outcomes of Rotational Acetabular Osteotomy Combined With Femoral Valgus Wedge Osteotomy for Osteoarthritis of the Hip: A Median 23-year Follow-Up Study of 47 Hips.

The Journal of arthroplasty·2026
Same author

Treatment Outcomes of Durvalumab Combination Therapy in Patients with Biliary Tract Cancer.

The Tokai journal of experimental and clinical medicine·2026
Same author

Clinical characteristics and anti-ZSCAN1 antibody titer analysis in a nationwide survey of ROHHAD (-NET) syndrome.

The Journal of clinical endocrinology and metabolism·2026
Same author

Femoral radiographic indices for pre-operative osteoporosis screening in postmenopausal female patients undergoing total hip arthroplasty for osteoarthritis.

PloS one·2026
Same author

Epidemiology of childhood cancer in Asia.

EClinicalMedicine·2025

Related Experiment Video

Updated: Feb 15, 2026

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

3.2K

Neuroblastoma.

Akira Nakagawara1,2, Yuanyuan Li3, Hideki Izumi3

  • 1Saga Medical Center Koseikan.

Japanese Journal of Clinical Oncology
|January 30, 2018
PubMed
Summary

Neuroblastoma, a common childhood cancer, shows diverse behaviors influenced by tumor biology. Advances in risk-stratified therapy have improved cure rates for high-risk neuroblastoma patients.

More Related Videos

Three-Dimensional In Vitro Biomimetic Model of Neuroblastoma Using Collagen-Based Scaffolds
07:48

Three-Dimensional In Vitro Biomimetic Model of Neuroblastoma Using Collagen-Based Scaffolds

Published on: July 9, 2021

4.0K
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
07:00

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

6.3K

Related Experiment Videos

Last Updated: Feb 15, 2026

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

3.2K
Three-Dimensional In Vitro Biomimetic Model of Neuroblastoma Using Collagen-Based Scaffolds
07:48

Three-Dimensional In Vitro Biomimetic Model of Neuroblastoma Using Collagen-Based Scaffolds

Published on: July 9, 2021

4.0K
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
07:00

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

6.3K

Area of Science:

  • Pediatric Oncology
  • Cancer Genomics
  • Tumor Biology

Background:

  • Neuroblastoma is a common pediatric solid tumor with variable clinical behavior.
  • Unique features include early onset, frequent metastasis in older children, and spontaneous regression in infants.
  • High-risk neuroblastoma is associated with MYCN amplification and chromosomal abnormalities, leading to poor survival.

Purpose of the Study:

  • To review the diverse clinical behavior and biology of neuroblastoma.
  • To highlight advancements in risk-stratified therapy and treatment outcomes.
  • To discuss future therapeutic strategies targeting novel drivers and the tumor microenvironment.

Main Methods:

  • Review of clinical studies and genomic sequencing data.
  • Analysis of risk-stratified therapy approaches.
  • Examination of treatment outcomes for different risk groups.

Main Results:

  • Risk-stratified therapy has reduced treatment intensity for low-risk neuroblastoma.
  • Significant improvements in cure rates for intermediate- and high-risk neuroblastoma have been achieved.
  • Therapy for high-risk disease involves intensive chemotherapy, differentiation therapy, and immunotherapy.

Conclusions:

  • Risk-stratified therapy has improved outcomes for children with neuroblastoma.
  • Future research focuses on novel therapeutic targets and the tumor microenvironment for better cures and quality of life.
  • Understanding neuroblastoma biology is crucial for developing effective, targeted treatments.